"Dry Powder Formulation Of Caveolin-1 Peptides And Methods Of Use Thereof" in Patent Application Approval Process (USPTO 20240269225).

The University of Texas System has filed a patent application for a dry powder formulation of caveolin-1 peptides and methods of use. The patent application describes the specific amino acid sequences of the peptides and their formulation, including particle size and water content. The invention also includes methods of treating chronic obstructive pulmonary disease (COPD) and other inflammatory or fibrotic conditions using the dry powder composition. This research has potential implications for the development of new drugs and therapies for lung diseases and conditions. [Extracted from the article]